Claire's Place Foundation Steps Up for Cystic Fibrosis Community in a Year Marked by Wildfires & Rising Costs As financial pressures on the cystic fibrosis community intensify, Claire's Place delivers rapid relief, creative fundraising & new long-term funding tools GlobeNewswire December 15, 2025 Los Angeles, CA, Dec. 15, 2025 (GLOBE NEWSWIRE) — Claire's Place Foundation, […]
Special Guests Including Billy Corgan, Chad Smith, and Luke Spiller and Curated Hotel Offerings Commemorate the 10 Year Anniversary of the Starman's Passing The Sun Rose West Hollywoodwelcomes music-loving travelers and locals alike to join internationally revered pianist Mike Garson – David Bowie's longest-serving and most frequently appearing band member – for an unforgettable three-night
NEW YORK, NY / ACCESS Newswire / December 15, 2025 / If you suffered a loss on your Avantor, Inc. (NYSE:AVTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://stockdropcenter.com/avantor,-inc.-lawsuit-submission-form?prid=180338&wire=1&utm_campaign=29 or call (212) 363-7500 to speak to our team of experienced shareholder
DUBAI, United Arab Emirates, Dec. 15, 2025 (GLOBE NEWSWIRE) — As early-stage DeFi projects mature, there is often a clear moment when progress moves from steady to accelerated. Mutuum Finance (MUTM) appears to be entering that phase now. With development advancing and participation continuing to build, the project is approaching a key point in its
Mutuum Finance (MUTM) Nears Full 100% Phase 6 Allocation as Presale Progresses Towards $20M Raised GlobeNewswire December 15, 2025 DUBAI, United Arab Emirates, Dec. 15, 2025 (GLOBE NEWSWIRE) — As early-stage DeFi projects mature, there is often a clear moment when progress moves from steady to accelerated. Mutuum Finance (MUTM) appears to be entering that
NEW YORK, NY / ACCESS Newswire / December 15, 2025 / If you suffered a loss on your Skye Bioscience, Inc. (NASDAQ:SKYE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://investorclaimform.com/skye-bioscience,-inc.-lawsuit-submission-form?prid=180343&wire=1&utm_campaign=29 or call (212) 363-7500 to speak to our team of experienced
(NASDAQ:DYAI), JUPITER, Fla., Dec. 15, 2025 (GLOBE NEWSWIRE) — Dyadic Applied BioSolutions (“Dyadic”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes across life science, food & nutrition, and bioindustrial markets today announced that it has entered into a commercial agreement with Opes Diagnostics Limited (“Opes”) to support the commercial launch of
(NYSE:PRGO), SAN DIEGO, Dec. 15, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Perrigo Company plc (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, inclusive (the “Class Period”), have until Friday, January 16, 2026 to seek appointment as lead plaintiff
Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic's Recombinant Growth Factors and Media Proteins GlobeNewswire December 15, 2025 JUPITER, Fla., Dec. 15, 2025 (GLOBE NEWSWIRE) — Dyadic Applied BioSolutions (“Dyadic”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes across life science, food & nutrition, and bioindustrial markets today
PRGO INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Perrigo Company plc Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit GlobeNewswire December 15, 2025 SAN DIEGO, Dec. 15, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Perrigo